Polaryx Therapeutics, Inc. Common Stock

PLYXNASDAQ • USD
1.61 USD
↘ 0.06 (3.53%)🟢LIVE (AS OF 01:06 PM EST)
🟢Market: OPEN

PLYX is currently priced at $1.61. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, PLYX is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.62
High?$1.86
Low?$1.59
Prev. Close?$1.67
Volume?21.4K
Avg. Volume?25.1K
VWAP?$1.68
Rel. Volume?0.85x
Bid / Ask
Bid?$1.35 × 100
Ask?$1.86 × 100
Spread?$0.51
Midpoint?$1.61
Valuation & Ratios
Market Cap?83.2M
Shares Out?N/A
Float?15.0M
Float %?30.1%
P/E Ratio?N/A
P/B Ratio?10.94
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
Employees
N/A
Market Cap
88.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-02-02
Address
140 EAST RIDGEWOOD AVENUE
PARAMUS, NJ 07652
Phone: 201-940-7236
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?0.92%Low
Short Interest?138.3K
Days to Cover?6.5
Free Float15.0M
Avg Daily Volume21.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.62Strong
Quick Ratio?8.62Strong
Cash Ratio?8.45Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
18
10.94HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-11.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-95.3%WEAK▾
ROA?
S&P
3
-84.2%WEAK▾
Cash Flow & Enterprise
FCF?$-7421000
Enterprise Value?$74.8M
Fundamentals ratios updated end of day